Genetic characterization of human immunodeficiency virus type 1 from Beira, Mozambique

Microbes and Infection

Volumn 8, Issue 9-10, 2006, Pages 2442-2451

  Parreira, Ricardo ^a   Piedade, João ^a   Domingues, Ana ^a   Lobão, Daniela ^a   Santos, Marisa ^a   Venenno, Teresa ^a   Baptista, João Luís ^b   Mussa, Selma A S ^c   Barreto, Avertino T L ^c   Baptista, Alberto João ^c   Esteves, Aida ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b NOVA MEDICAL SCHOOL   (Portugal)

^c Ministério da Saúde de Moçambique ^*  (Mozambique)

Author keywords

Drug resistance; HIV 1; LTR; Mozambique; Subtype C

Indexed keywords

GAG PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LTR PROTEIN; PROTEIN; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; BINDING SITE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DNA SEQUENCE; ENVELOPE GENE; FEMALE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS STRAIN;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOZAMBIQUE; PHYLOGENY; PREGNANCY; SEQUENCE ALIGNMENT;

DORCATRAGUS MEGALOTIS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33749368316     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.05.005     Document Type: Article

References (42)

1. Thomson M.M., Pérez-Álvarez L., and Nájera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect. Dis. 2 (2002) 461-471
2. Bredell H., Williamson C., Sonnenberg P., Martin D.J., and Morris L. Genetic characterization of HIV type 1 from migrant workers in three South African gold mines. AIDS Res. Hum. Retroviruses 14 (1998) 677-684
3. Engelbrecht S., Laten J.D., Smith T.L., and van Rensburg E.J. Identification of env subtypes in fourteen HIV type 1 isolates from South Africa. AIDS Res. Hum. Retroviruses 11 (1995) 1269-1271
4. Alaeus A., Leitner T., Lidman K., and Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 11 (1997) 199-202
5. De Baar M.P., De Ronde A., Berkhout B., Cornelissen M., Van Der Horn K.H., Van Der Schoot A.M., De Wolf F., Lukashov V.V., and Goudsmit J. Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site. AIDS Res. Hum. Retroviruses 16 (2000) 499-504
6. Engelbrecht S., Koulinska I., Smith T.-L., Barreto J., and van Rensburg E.J. Variation in HIV type 1 V3 region env sequences from Mozambique. AIDS Res. Hum. Retroviruses 14 (1998) 803-805
7. Downing R., Pieniazek D., Hu D.J., Biryahwaho B., Fridlund C., Rayfield M.A., Sempala S.D., and Lal R.B. Genetic characterization and phylogenetic analysis of HIV-1 subtype C from Uganda. AIDS Res. Hum. Retroviruses 16 (2000) 815-819
8. Bellocchi M.C., Forbici F., Palombi L., Gori C., Coelho E., Svicher V., D'Arrigo R., Emberti-Gialloreti L., Ceffa S., Erba F., Marazzi M.C., Silberstein F.C., and Perno C.F. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme. J. Med. Virol. 76 (2005) 452-458
9. Delwart E.L., Herring B., Rodrigo A.G., and Mullins J.I. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. PCR Methods Appl. 4 (1995) S202-S216
10. Heyndrickx L., Janssens W., Zekeng L., Musonda R., Anagonou S., van der Auwera G., Coppens S., Vereecken K., de Witte K., van Rampelbergh R., Kahindo M., Morison L., McCutchan F.E., Carr J.K., Albert J., Essex M., Goudsmit J., Äsjo B., Salminen M., Buvé A., and van der Groen G. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J. Virol. 74 (2000) 363-370
11. Kumar S., Tamura K., Jakobsen I.B., and Nei M. MEGA2: Molecular evolutionary genetics analysis software. Bioinformatics 17 (2001) 1244-1245
12. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., Ingersoll R., Sheppard H.W., and Ray S.C. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73 (1999) 152-160
13. Nei M., and Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3 (1986) 418-426
14. Jensen M.A., Li F.-S., van't Wout A.B., Nickle D.C., Shriner D., He H.X., McLaughlin S., Shankarappa R., Margolick J.B., and Mullins J.I. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 77 (2003) 13376-13388
15. Johnson V.A., Brun-Vézinet F., Clotet B., Conway B., Kuritzkes D.R., Pillay D., Schapiro J., Telenti A., and Richman D. Update of the drug resistance mutations in HIV-1: 2005. Top. HIV Med. 13 (2005) 51-57
16. Naghavi M.H., Estable M.C., Schwartz S., Roeder R.G., and Vahlne A. Upstream stimulating factor affects human immunodeficiency virus type 1 (HIV-1) long terminal repeat-directed transcription in a cell-specific manner, independently of the HIV-1 subtype and the core-negative regulatory element. J. Gen. Virol. 82 (2001) 547-559
17. van Lint C., Amella C.A., Emiliani S., John M., Jie T., and Verdin E. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 71 (1997) 6113-6127
18. Tanaka N., Kawakami T., and Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13 (1993) 4531-4538
19. Loemba H., Brenner B., Parniak M.A., Ma'ayan S., Spira B., Moisi D., Oliveira M., Detorio M., and Wainberg M.A. Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Antimicrob. Agents Chemother. 46 (2002) 2087-2094
20. Brenner B., Turner D., Oliveira M., Moisi D., Detorio M., Carobene M., Marlink R.G., Schapiro J., Roger M., and Wainberg M.A. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 17 (2003) F1-F5
21. Robertson D.L., Sharp P.M., McCutchan F.E., and Hahn B.H. Recombination in HIV-1. Nature 374 (1995) 124-126
22. Robertson D.L., Hahn B.H., and Sharp P.M. Recombination in AIDS viruses. J. Mol. Evol. 40 (1995) 249-259
23. Hoelscher M., Kim B., Maboko L., Mhalu F., von Sonnenburg F., Birx D.L., and McCutchan F.E. UNAIDS Network for HIV Isolation and Characterization, High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania. AIDS 15 (2001) 1461-1470
24. Li Y., Rey-Cuille M.A., and Hu S.-L. N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection. AIDS Res. Hum. Retroviruses 17 (2001) 1473-1479
25. Pollakis G., Kang S., Kliphuis A., Chalaby M.I., Goudsmit J., and Paxton W.A. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J. Biol. Chem. 276 (2001) 13433-13441
26. Peeters M., Vincent R., Perret J.L., Lasky M., Patrel D., Liegeois F., Courgnaud V., Seng R., Matton T., Molinier S., and Delaporte E. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20 (1999) 115-121
27. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D., Novitsky V., Haynes B., Hahn B.H., Bhattacharya T., and Korber B. Diversity considerations in HIV-1 vaccine selection. Science 296 (2002) 2354-2360
28. Choisy M., Woelk C.H., Guégan J.-F., and Robertson D.L. Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J. Virol. 78 (2004) 1962-1970
29. van Opijnen T., Jeeninga R.E., Boerlijst M.C., Pollakis G.P., Zetterberg V., Salminen M., and Berkhout B. Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J. Virol. 78 (2004) 3675-3683
30. Naghavi M.H., Salminen M.O., Sönnerborg A., and Vahlne A. DNA sequence of the long terminal repeat of human immunodeficiency virus type 1 subtype A through G. AIDS Res. Hum. Retroviruses 15 (1999) 485-488
31. Naghavi M.H., Schwartz S., Sönnerborg A., and Vahlne A. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res. Hum. Retroviruses 15 (1999) 1293-1303
32. Jeeninga R.E., Hoogenkamp M., Armand-Ugon M., de Baar M., Verhoef K., and Berkhout B. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J. Virol. 74 (2000) 3740-3751
33. Montano M.A., Nixon C.P., Ndung'u T., Bussmann H., Novitsky V.A., Dickman D., and Essex M. Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. J. Infect. Dis. 181 (2000) 76-81
34. Novitsky V., Smith U.R., Gilbert P., McLane M.F., Chigwedere P., Williamson C., Ndung'u T., Klein I., Chang S.Y., Peter T., Thior I., Foley B.T., Gaolekwe S., Rybak N., Gaseitsiwe S., Vannberg F., Marlink R., Lee T.H., and Essex M. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?. J. Virol. 76 (2002) 5435-5451
35. Battistini A., Marsili G., Sgarbanti M., Ensoli B., and Hiscott J. IRF regulation of HIV-1 long terminal repeat activity. J. Interferon Cytokine Res. 22 (2002) 27-37
36. L.A. Petch, I.F. Hoffman, C.S. Jere, P.N. Kazembe, F.E. Martinson, D. Chilongozi, M.S. Cohen, S.A. Fiscus, Genotypic analysis of the protease and reverse transcriptase of HIV-1 subtype C isolates from untreated patients in Malawi, 14th International AIDS Conference, Barcelona 2002[abstract TuPeB4623].
37. Pillay C., Bredell H., McIntyre J., Gray G., and Morris L. HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa. AIDS Res. Hum. Retroviruses 18 (2002) 605-610
38. Gordon M., de Oliveira T., Bishop K., Coovadia H.M., Madurai L., Engelbrecht S., van Rensburg E.J., Mosam A., Smith A., and Cassol S. Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: Implications for vaccine and antiretroviral control strategies. J. Virol. 77 (2003) 2587-2599
39. Handema R., Terunuma H., Kasolo F., Kasai H., Sichone M., Yamashita A., Deng X., Mulundu G., Ichiyama K., Munkanta M., Yokota T., Wakasugi N., Tezuka F., Yamamoto N., and Ito M. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naïve Zambians infected with subtype C HIV-1. AIDS Res. Hum. Retroviruses 19 (2003) 151-160
40. Bessong P.O., Obi C.L., Cilliers T., Choge I., Phoswa M., Pillay C., Papathanasopoulos M., and Morris L. Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV type 1 prevalence. AIDS Res. Hum. Retroviruses 21 (2005) 103-109
41. Bussmann H., Novitsky V., Wester W., Peter T., Masupu K., Gabaitiri L., Kim S., Gaseitsiwe S., Ndung'u T., Marlink R., Thior I., and Essex M. HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. Antivir. Chem. Chemother. 16 (2005) 103-115
42. Shafer R.W., Chuang T.K., Hsu P., White C.B., and Katzenstein D.A. Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. AIDS Res. Hum. Retroviruses 15 (1999) 65-69